Stockreport

Annexon Reports Third Quarter 2024 Portfolio and Financial Results, and Key Anticipated Milestones [Yahoo! Finance]

Annexon, Inc. - common stock  (ANNX) 
PDF Ongoing Enrollment in Phase 3 ARCHER II Trial for ANX007 in Geographic Atrophy (GA); Topline Data Expected Second Half 2026 Proof-of-Concept Study with First-in-Kind [Read more]